Gut-Brain Axis Assessment · Phenotype

The Serotonin-Starved Neurobiome Phenotype

GoodOnes Neurobiome · Phenotype · NEURO 03 Flow · ~24% of people

Measured serotonin-precursor and bile-acid capacity read low — the slow-gut, flat-mood pattern.
POTENTIATE bile / 5-HT

In plain terms

Most of your body's serotonin is made in the gut, and it rides on healthy bile-acid signaling. In this phenotype the measured capacity for both runs light — the serotonin-precursor (tryptamine) pathway and bile-salt hydrolase both read below the cohort mean.

That combination tends to show up as a slow, constipated, bloated gut and a flat, low mood — the machinery that keeps things moving and lifts affect is under-powered.

The move is to potentiate the bile-acid and serotonin rack and get things flowing again.

The gut-brain mechanism, in depth

Serotonin (5-HT) in the gut sets motility and feeds the gut-brain conversation; it is built from tryptophan. When microbes shunt tryptophan down the indole route (tnaA) instead, less is available for serotonin — and in this phenotype the indole shunt reads high while the serotonin-precursor capacity reads low. Bile-salt hydrolase (bsh), which shapes the bile-acid signals that also drive motility, reads low as well.

Low serotonin and bile-acid signaling slow transit (constipation, bloating, reflux) and blunt the upward mood signal. The formula answer is to potentiate: rebuild bile-acid and serotonin capacity, spare tryptophan toward serotonin, and add Lion's Mane for mood, cognition and gut-lining support.

Your measured signature

Measured functional capacity across the 11 gut-brain pathways — read from targeted gene markers in your sequencing data (not inferred from which microbes are present), and CLR-normalized so pathways compare across people. In this phenotype (measured prevalence 23.6%, n = 988 of ~4,194 clustered samples) the standout readings are:

Tryptamine — serotonin precursor (tdc) ▼ low z = -0.96
Bile-salt hydrolase (bsh) ▼ low z = -0.91
GABA production (gadB) ▲ high z = +0.77
Indole / tryptophan shunt (tnaA) ▲ high z = +0.75
Butyrate — but route ▼ low z = -0.67
Histamine (hdc) ▲ high z = +0.56

z = standard deviations from the cohort mean. These clusters come from the measured capacity alone and are not an artifact of sequencing batch (cluster/run agreement ≈ 0).

Signature chart — measured capacity across the 11 gut-brain pathways

cohort mean (z=0)Butyrate — buk route+0.49Butyrate — but route-0.67Bile-salt hydrolase (bsh)-0.91GABA production (gadB)+0.77Tryptamine — serotonin precursor (tdc)-0.96Indole / tryptophan shunt (tnaA)+0.75Histamine (hdc)+0.56Tyramine (tyrDC)-0.36p-cresol (hpdB)-0.27Polyamine (speA)+0.12Polyamine (speC)-0.26

How common is this phenotype?

Where your pattern sits among the six measured phenotypes:

NEURO 01 Steady26.4%NEURO 02 Settle24.6%NEURO 03 Flow23.6%NEURO 04 Calm14.6%NEURO 05 Cool8.8%NEURO 06 Rebuild2.1%

Does this sound like you?

Framed as tendencies, not a diagnosis:

In the gut: Constipation, bloating, a sluggish 'nothing's moving' gut; reflux; feeling worse after big meals.

In mood & mind: Flat, low or foggy mood; low drive; the sense that gut and mood sink together.

What the data shows

Across our microbiome dataset (n = 1,009 in this phenotype), these self-reported conditions were more common in this pattern than at baseline — associations, not a diagnosis:

Constipation 56% report it OR 1.52 q = 0.000
IBS 31% report it OR 1.42 q = 0.000
Hypothyroidism 22% report it OR 1.36 q = 0.010
Gastroesophageal reflux disease (GERD) 21% report it OR 1.35 q = 0.011
Arthritis 14% report it OR 1.38 q = 0.033
Stomach pain 38% report it OR 1.25 q = 0.033

Shown: associations passing FDR (q < 0.05).

FDR-significant (q<0.05) associations:

OR 1ConstipationOR 1.52 · q=0.000IBSOR 1.42 · q=0.000HypothyroidismOR 1.36 · q=0.010Gastroesophageal reflux disease (GEROR 1.35 · q=0.011ArthritisOR 1.38 · q=0.033Stomach painOR 1.25 · q=0.033

What your formula does

The matched formula’s action is POTENTIATE bile / 5-HT — rebuild the depleted pathway by adding producing strains and supplying the metabolite directly.

Neuro-actives layered on the probiotic base:

❋ Lion's Mane (botanical)

Take it into your own hands

Your phenotype points to specific, self-directed levers — the “be your own biohacker” angle. None of this is medical treatment; it’s how to feed the pathway the measurement flagged:

  • Feed butyrate and serotonin machinery with fiber diversity and resistant starch (cooled potato or rice, slightly-green banana, legumes, oats).
  • Add polyphenols — berries, extra-virgin olive oil, cocoa, green tea — to support beneficial producers.
  • Get enough tryptophan (adequate protein) so there's raw material for serotonin.
  • Move daily and keep meal timing regular — motility responds to rhythm and activity; stay well hydrated.

One honest caveat

Your quiz result is a symptom-based pattern, not a verdict — and symptoms are orthogonal to biology, so a measured gut test is what confirms your true phenotype. Everything here is educational and non-therapeutic: formulas potentiate, suppress or support gut-brain pathways; they do not treat, cure or diagnose disease.

Your matched formula

Your result matches the GoodOnes formula built for this gut-brain pattern: Flow. Start there — or confirm your true phenotype first with a measured whole-genome (WGS) test.

See the Flow formula →
Non-therapeutic: potentiate / suppress / support — never treat, cure or diagnose. By GoodOnes™ · Real Good Ones. Capsules or powder, never liquid.

Confirm it with a test

This result is a symptom-based read — a strong starting point, not a verdict. Symptoms and your actual gut biology are only loosely linked, so the one way to know your true phenotype is to measure it. A whole-genome (WGS) microbiome test reads the real gut-brain gene signatures shown above — the same pathways (butyrate, GABA, serotonin, bile acids) — from your own sequencing data, so your formula is built on measured capacity, not a guess.

Measure your neurobiome →